Products
525 products
| Code | Description | Unit |
|---|---|---|
| SAF-PHR1351-1G | myo-Inositol, pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1280-1G | Xylit, pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1478-500MG | 4-Chloro-3,5-dimethylphenol, pharmaceutical secondary standard, traceable to USP | 500 mg |
| SAF-PHR1740-200MG | 1-Vinyl-2-pyrrolidinone, pharmaceutical secondary standard | 200 mg |
| SAF-PHR1473-500MG | o-Toluenesulfonamide, pharmaceutical secondary standard, traceable to USP | 500 mg |
| SAF-PHR1648-30MG | Omeprazole Sulfone, pharmaceutical secondary standard, traceable to USP, PhEur | 30 mg |
| SAF-PHR1060-1G | 5-Aminosalicylic acid, pharmaceutical secondary standard, traceable to USP, PhEur and BP | 1 g |
| SAF-PHR1686-1G | Tazobactam | 1 g |
| SAF-PHR1134-1G | Thymol, pharmaceutical secondary standard, traceable to USP | 1 g |
| SAF-PHR1458-1G | CARRAGEENAN | 1 g |
| SAF-PHR1250-500MG | Crospovidone, pharmaceutical secondary standard, traceable to USP and PhEur | 500 mg |
| SAF-PHR1463-1G | Crospovidone | 1 g |
| SAF-05485001-150MG | Ginkgo biloba extractsecondary pharmaceutical standard | 150 mg |
| SAF-PHR1374-1G | Ethylcellulose | 1 g |
| SAF-PHR1485-1G | Hydroxypropyl Cellulose, pharmaceutical secondary standard, traceable to USP | 1 g |
| SAF-PHR1829-500MG | Hypromellose (Hydroxypropyl Methylcellulose) | 500 mg |
| SAF-PHR1136-1.5G | 2-Hydroxyanisole (Guaiacol), pharmaceutical secondary standard, traceable to USP and PhEur | 1,5 g |
| SAF-PHR1471-1G | Sodium Alginate, pharmaceutical secondary standard | 1 g |
| SAF-PHR1466-1G | Polydimethylsiloxane | 1 g |
| SAF-PHR1518-1G | Polydimethylsiloxane | 1 g |
| SAF-PHR1678-1G | Bicalutamide, pharmaceutical secondary standard, traceable to USP, PhEur, BP | 1 g |
| SAF-PHR1522-500MG | Dalteparin sodium | 500 mg |
| SAF-PHR1310-1G | Mineral Spirits, pharmaceutical secondary standard, traceable to USP | 1 g |
| SAF-PHR1786-500MG | Chondroitin Sulfate Sodium | 500 mg |
| SAF-PHR1275-1G | Naphthalene, pharmaceutical secondary standard, traceable to USP | 1 g |
| SAF-PHR1773-100MG | 5-[[(2-Aminoethyl)thio]methyl]-N,N-dimethyl-2-furanmethanamine hemifumarate, pharmaceutical secondary standard, traceable to USP | 100 mg |
| SAF-PHR1633-200MG | Ropinirole Hydrochloride, pharmaceutical secondary standard, traceable to USP, PhEur | 200 mg |
| SAF-PHR1193-500MG | (3,4-Dimethoxyphenyl)-methanol, pharmaceutical secondary standard, traceable to USP | 500 mg |
| SAF-PHR1513-500MG | Enrofloxacin, pharmaceutical secondary standard, traceable to USP, PhEur | 500 mg |
| SAF-PHR1027-1G | Guaifenesin, pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1617-1G | Glimepiride, pharmaceutical secondary standard, traceable to USP, PhEur, BP | 1 g |
| SAF-PHR1835-500MG | Methyl nicotinate | 500 mg |
| SAF-PHR1620-1G | Fluvastatin Sodium, pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1010-10G | 4-Hydroxybenzoic acid-propyl ester, pharmaceutical secondary standard, traceable to USP and PhEur | 10 g |
| SAF-PHR1010-1G | 4-Hydroxybenzoic acid-propyl ester, pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1284-1G | Chlorpropamide, pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1695-50MG | 1-(3-Hydroxyphenyl)-2-(methylamino)ethan-1-one hydrochloride, pharmaceutical secondary standard | 50 mg |
| SAF-PHR1711-50MG | 1-(3-Hydroxyphenyl)-2-(methylamino)ethan-1-one hydrochloride | 50 mg |
| SAF-PHR1022-1G | 4-Hydroxybenzoic acid-n-butyl ester, pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1370-1ML | Benzyl Nicotinate, pharmaceutical secondary standard | 1 mL |
| SAF-PHR1591-500MG | Atovaquone, pharmaceutical secondary standard, traceable to USP, PhEur | 500 mg |
| SAF-PHR1312-1G | LM-Xylenesecondary standard traceable to NIST | 1 g |
| SAF-PHR1739-200MG | 2-Aminophenol, pharmaceutical secondary standard, traceable to PhEur | 200 mg |
| SAF-PHR1501-1G | Aminobutanol, pharmaceutical secondary standard, traceable to USP | 1 g |
| SAF-PHR1430-1G | Dihydroxyacetone, pharmaceutical secondary standard, traceable to USP | 1 g |
| SAF-PHR1445-1G | Orlistat, pharmaceutical secondary standard, traceable to USP | 1 g |
| SAF-PHR1600-1G | Topiramate, pharmaceutical secondary standard, traceable to USP | 1 g |
| SAF-PHR1269-1G | Eugenol, pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1364-500MG | Allantoin, pharmaceutical secondary standard, traceable to USP and PhEur | 500 mg |
| SAF-PHR1690-1G | Disulfiram | 1 g |
| SAF-PHR1779-1G | Betamethasone Acetate | 1 g |
| SAF-PHR1210-3X1.2ML | Cumene, pharmaceutical secondary standard, traceable to USP | 3 x 1,2 mL |
| SAF-PHR1033-1G | Free Vitamin B3 (as Niacinamide), pharmaceutical secondary standard, traceable to USP, PhEur and BP | 1 g |
| SAF-PHR1333-1G | (-)-Epigallocatechin gallate, pharmaceutical secondary standard, traceable to USP | 1 g |
| SAF-PHR1576-500MG | Pyrazinamide, pharmaceutical secondary standard, traceable to USP, PhEur, BP | 500 mg |
| SAF-PHR1743-200MG | 3-Aminobenzoic acid, pharmaceutical secondary standard | 200 mg |
| SAF-PHR1736-1G | Venlafaxine Hydrochloride, pharmaceutical secondary standard, traceable to USP, PhEur | 1 g |
| SAF-PHR1061-1G | Valproic acid, pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1652-0.5ML | Diallylacetic Acid, pharmaceutical secondary standard, traceable to USP | 0,5 mL |
| SAF-PHR1012-10G | 4-Hydroxybenzoic acid-methyl ester, pharmaceutical secondary standard, traceable to USP and PhEur | 10 g |
| SAF-PHR1012-1G | 4-Hydroxybenzoic acid-methyl ester, pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1747-200MG | 4'-Aminoacetophenone, pharmaceutical secondary standard | 200 mg |
| SAF-PHR1048-1G | 4-hydroxybenzoic acid, pharmaceutical secondary standard, traceable to USP | 1 g |
| SAF-05095001-150MG | Crataegus spp. Extract, secondary pharmaceutical standard | 150 mg |
| SAF-05115001-150MG | Panax ginseng extract, secondary pharmaceutical standard | 150 mg |
| SAF-05495001-150MG | Camellia sinensis extract, secondary pharmaceutical standard | 150 mg |
| SAF-PHR1078-1G | Phytonadione, pharmaceutical secondary standard, traceable to USP, PhEur and BP | 1 g |
| SAF-PHR1079-1G | Tobramycin, pharmaceutical secondary standard, traceable to USP, PhEur and BP | 1 g |
| SAF-PHR1096-1G | L-Lysine Acetate, pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1098-1G | N-Acetyl-L-cysteine, pharmaceutical secondary standard, traceable to USP, PhEur and BP | 1 g |
| SAF-PHR1100-1G | L-Phenylalanine, pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1114-1G | Octadecanoic acid (Stearic acid) (C18:0), pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1115-1G | Steary Alcohol, pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1116-1G | L-Menthol, pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1117-1G | Butylated Hydroxytoluene, pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1118-1G | Propyl Gallate, pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1120-1G | Hexadecanoic acid (Palmitic acid) (C16:0), pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1122-1.5G | Phenylethyl Alcohol, pharmaceutical secondary standard, traceable to USP | 1,5 g |
| SAF-PHR1123-1G | Isopropyl Myristate, pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1124-1G | Tetradecanoic acid (Myristic acid) (C14:0), pharmaceutical secondary standard, traceable to USP | 1 g |
| SAF-PHR1125-1G | L-Glutamine, pharmaceutical secondary standard, traceable to USP | 1 g |
| SAF-PHR1127-1G | Amoxicillin trihydrate, pharmaceutical secondary standard, traceable to USP, PhEur and BP | 1 g |
| SAF-PHR1129-1G | Tetracaine Hydrochloride, pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1130-1G | Potassium Gluconate, pharmaceutical secondary standard, traceable to USP | 1 g |
| SAF-PHR1132-1G | Metoclopramide hydrochloride, pharmaceutical secondary standard, traceable to USP, PhEur and BP | 1 g |
| SAF-PHR1133-1G | Cetyl Alcohol, pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1135-1G | Myristyl Alcohol, pharmaceutical secondary standard, traceable to USP | 1 g |
| SAF-PHR1137-1G | Isopropyl Palmitate, pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1139-1G | Phenytoin, pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1140-500MG | Ketorolac Tromethamine, pharmaceutical secondary standard, traceable to USP and PhEur | 500 mg |
| SAF-PHR1141-1G | Ondansetron hydrochloride, pharmaceutical secondary standard, traceable to USP, PhEur and BP | 1 g |
| SAF-PHR1142-1G | Progesterone, pharmaceutical secondary standard, traceable to USP, PhEur and BP | 1 g |
| SAF-PHR1143-1G | Lisinopril, pharmaceutical secondary standard, traceable to USP, PhEur and BP | 1 g |
| SAF-PHR1145-1G | Doxycycline hyclate, pharmaceutical secondary standard, traceable to USP, PhEur and BP | 1 g |
| SAF-PHR1148-1G | 4-Aminophenol, pharmaceutical secondary standard, traceable to USP | 1 g |
| SAF-PHR1149-1G | 4-Chloroacetanilide, pharmaceutical secondary standard | 1 g |
| SAF-PHR1152-1G | Phenyl salicylate melting point standard , pharmaceutical secondary standard, traceable to USP | 1 g |
| SAF-PHR1154-1G | Tributyl Citrate, pharmaceutical secondary standard, traceable to USP | 1 g |
| SAF-PHR1155-1G | Octyldodecanol, pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |
| SAF-PHR1156-1G | Acetyltributyl Citrate, pharmaceutical secondary standard, traceable to USP and PhEur | 1 g |